Loading…

Loading grant details…

Completed HORIZON European Commission

RondelO - the first medical stopcock designed for sequential intraveneous infusion of incompatible drugs

€2.77M EUR

Funder European Commission
Recipient Organization Cyto365 Ab
Country Sweden
Start Date Nov 01, 2022
End Date Apr 30, 2025
Duration 911 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190103560
Grant Description

CYTO365 is developing RondeO® - a revolutionary medical stopcock to be used with intravenous drug administration sets (IV sets).

RondelO® is the first medical device that allows for a sequential intravenous administration of up to 6 drugs with the neutral saline in between the drugs.

RondelO® aids the nurse to administer drugs to the patient safely and correctly, by letting only one drug pass at a time.

It solves the problem of serious side effects caused by drug incompatibility by eliminating human error and unwanted parallel infusion and thereby increases patient safety.

Moreover, RondelO® is easy to use (minimal training required), safe for the user (Closed System Valve (CSV) minimizes hazardous drug expose for the nurse), customizable (different configurations with 2, 4 or 6 drug inlets with or without CSV available) and time-efficient (all drugs are connected to IV set at the beginning of the procedure).

All Grantees

Cyto365 Ab

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant